Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2004 Jan;75(1):110–115.

Abnormal baroreceptor-mediated vasopressin release as possible marker in early diagnosis of multiple system atrophy

K Deguchi 1, I Sasaki 1, T Touge 1, M Tsukaguchi 1, H Takeuchi 1, S Kuriyama 1
PMCID: PMC1757439  PMID: 14707318

Abstract

Background: Although autonomic failure (AF) is a critical symptom of multiple system atrophy (MSA), it may not appear until late in the disease process.

Objectives: To clarify whether a detailed investigation of the autonomic nervous system in patients with MSA without overt AF demonstrates latent lesions of central cardiovascular control circuits and facilitates the early diagnosis of MSA.

Methods: Autonomic function tests, and plasma noradrenaline (NA) and vasopressin (AVP) responses to head-up tilt (HUT), were studied in 12 patients with MSA with AF (probable MSA), 12 with MSA without overt AF (possible MSA), and 24 controls.

Results: Abnormalities of cardiovascular autonomic function tests were prominent in the first group but mild in the second. Plasma NA and AVP increments upon HUT differed significantly among all three groups.

Conclusions: These results indicate that probable MSA involves diffuse degeneration of central cardiovascular control circuits. On the other hand, the discrepancies in possible MSA suggest a vulnerability of the noradrenergic (A1) neurones of the caudal ventrolateral medulla that are involved in AVP secretion. This finding also suggests that AVP increment may be useful as a diagnostic tool in the early stages of MSA.

Full Text

The Full Text of this article is available as a PDF (246.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baylis P. H., Heath D. A. Influence of presyncope and postural change upon plasma arginine vasopressing concentration in hydrated and dehydrated man. Clin Endocrinol (Oxf) 1977 Jul;7(1):79–83. doi: 10.1111/j.1365-2265.1977.tb02942.x. [DOI] [PubMed] [Google Scholar]
  2. Baylis P. H. Posterior pituitary function in health and disease. Clin Endocrinol Metab. 1983 Nov;12(3):747–770. doi: 10.1016/s0300-595x(83)80063-2. [DOI] [PubMed] [Google Scholar]
  3. Benarroch E. E., Schmeichel A. M., Parisi J. E. Involvement of the ventrolateral medulla in parkinsonism with autonomic failure. Neurology. 2000 Feb 22;54(4):963–968. doi: 10.1212/wnl.54.4.963. [DOI] [PubMed] [Google Scholar]
  4. Benarroch E. E., Smithson I. L., Low P. A., Parisi J. E. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure. Ann Neurol. 1998 Feb;43(2):156–163. doi: 10.1002/ana.410430205. [DOI] [PubMed] [Google Scholar]
  5. Benarroch Eduardo E. New findings on the neuropathology of multiple system atrophy. Auton Neurosci. 2002 Feb 28;96(1):59–62. doi: 10.1016/s1566-0702(01)00374-5. [DOI] [PubMed] [Google Scholar]
  6. Davie C. A., Wenning G. K., Barker G. J., Tofts P. S., Kendall B. E., Quinn N., McDonald W. I., Marsden C. D., Miller D. H. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol. 1995 Feb;37(2):204–210. doi: 10.1002/ana.410370211. [DOI] [PubMed] [Google Scholar]
  7. Friess E., Kuempfel T., Winkelmann J., Schmid D., Uhr M., Rupprecht R., Holsboer F., Trenkwalder C. Increased growth hormone response to apomorphine in Parkinson disease compared with multiple system atrophy. Arch Neurol. 2001 Feb;58(2):241–246. doi: 10.1001/archneur.58.2.241. [DOI] [PubMed] [Google Scholar]
  8. Gilman S., Little R., Johanns J., Heumann M., Kluin K. J., Junck L., Koeppe R. A., An H. Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy. Neurology. 2000 Aug 22;55(4):527–532. doi: 10.1212/wnl.55.4.527. [DOI] [PubMed] [Google Scholar]
  9. Gilman S., Low P. A., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C. J., Kaufmann H., Klockgether T., Lang A. E., Lantos P. L. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999 Feb 1;163(1):94–98. doi: 10.1016/s0022-510x(98)00304-9. [DOI] [PubMed] [Google Scholar]
  10. Goldstein D. S., Holmes C., Cannon R. O., 3rd, Eisenhofer G., Kopin I. J. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med. 1997 Mar 6;336(10):696–702. doi: 10.1056/NEJM199703063361004. [DOI] [PubMed] [Google Scholar]
  11. Hakusui S., Yasuda T., Yanagi T., Tohyama J., Hasegawa Y., Koike Y., Hirayama M., Takahashi A. A radiological analysis of heart sympathetic functions with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst. 1994 Sep;49(1):81–84. doi: 10.1016/0165-1838(94)90023-x. [DOI] [PubMed] [Google Scholar]
  12. Kato S., Oda M., Hayashi H., Shimizu T., Hayashi M., Kawata A., Tanabe H. Decrease of medullary catecholaminergic neurons in multiple system atrophy and Parkinson's disease and their preservation in amyotrophic lateral sclerosis. J Neurol Sci. 1995 Oct;132(2):216–221. doi: 10.1016/0022-510x(95)00155-u. [DOI] [PubMed] [Google Scholar]
  13. Kaufmann H., Oribe E., Miller M., Knott P., Wiltshire-Clement M., Yahr M. D. Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure. Neurology. 1992 Mar;42(3 Pt 1):590–593. doi: 10.1212/wnl.42.3.590. [DOI] [PubMed] [Google Scholar]
  14. Kimber J. R., Watson L., Mathias C. J. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine. Lancet. 1997 Jun 28;349(9069):1877–1881. doi: 10.1016/s0140-6736(96)10168-9. [DOI] [PubMed] [Google Scholar]
  15. Kimber J., Mathias C. J., Lees A. J., Bleasdale-Barr K., Chang H. S., Churchyard A., Watson L. Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy. Brain. 2000 Jul;123(Pt 7):1422–1430. doi: 10.1093/brain/123.7.1422. [DOI] [PubMed] [Google Scholar]
  16. Kimber J., Watson L., Mathias C. J. Abnormal suppression of arginine-vasopressin by clonidine in multiple system atrophy. Clin Auton Res. 1999 Oct;9(5):271–274. doi: 10.1007/BF02319457. [DOI] [PubMed] [Google Scholar]
  17. Kimber J., Watson L., Mathias C. J. Neuroendocrine responses to levodopa in multiple system atrophy (MSA). Mov Disord. 1999 Nov;14(6):981–987. doi: 10.1002/1531-8257(199911)14:6<981::aid-mds1011>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  18. Lantos P. L. The definition of multiple system atrophy: a review of recent developments. J Neuropathol Exp Neurol. 1998 Dec;57(12):1099–1111. doi: 10.1097/00005072-199812000-00001. [DOI] [PubMed] [Google Scholar]
  19. Malessa S., Hirsch E. C., Cervera P., Duyckaerts C., Agid Y. Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration. Neurology. 1990 Nov;40(11):1739–1743. doi: 10.1212/wnl.40.11.1739. [DOI] [PubMed] [Google Scholar]
  20. Mosqueda-Garcia R., Furlan R., Tank J., Fernandez-Violante R. The elusive pathophysiology of neurally mediated syncope. Circulation. 2000 Dec 5;102(23):2898–2906. doi: 10.1161/01.cir.102.23.2898. [DOI] [PubMed] [Google Scholar]
  21. Niimi Y., Ieda T., Hirayama M., Koike Y., Sobue G., Hasegawa Y., Takahashi A. Clinical and physiological characteristics of autonomic failure with Parkinson's disease. Clin Auton Res. 1999 Jun;9(3):139–144. doi: 10.1007/BF02281627. [DOI] [PubMed] [Google Scholar]
  22. Norbiato G., Bevilacqua M., Righini V., Chebat E., Vago T., Bertora P., Castelli L., Mangoni A. Altered vasopressin response to metoclopramide in multiple system atrophy: evidence of a cholinergic defect in the hypothalamus. Acta Neurol Scand. 1992 Apr;85(4):299–303. doi: 10.1111/j.1600-0404.1992.tb04047.x. [DOI] [PubMed] [Google Scholar]
  23. Nussey S. S., Hawthorn J., Page S. R., Ang V. T., Jenkins J. S. Responses of plasma oxytocin and arginine vasopressin to nausea induced by apomorphine and ipecacuanha. Clin Endocrinol (Oxf) 1988 Mar;28(3):297–304. doi: 10.1111/j.1365-2265.1988.tb01216.x. [DOI] [PubMed] [Google Scholar]
  24. Oppenheimer D. R. Lateral horn cells in progressive autonomic failure. J Neurol Sci. 1980 Jun;46(3):393–404. doi: 10.1016/0022-510x(80)90064-7. [DOI] [PubMed] [Google Scholar]
  25. Orimo S., Ozawa E., Nakade S., Sugimoto T., Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):189–194. doi: 10.1136/jnnp.67.2.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Parikh Samir M., Diedrich André, Biaggioni Italo, Robertson David. The nature of the autonomic dysfunction in multiple system atrophy. J Neurol Sci. 2002 Aug 15;200(1-2):1–10. doi: 10.1016/s0022-510x(02)00126-0. [DOI] [PubMed] [Google Scholar]
  27. Polinsky R. J., Kopin I. J., Ebert M. H., Weise V. Pharmacologic distinction of different orthostatic hypotension syndromes. Neurology. 1981 Jan;31(1):1–7. doi: 10.1212/wnl.31.1.1. [DOI] [PubMed] [Google Scholar]
  28. Puritz R., Lightman S. L., Wilcox C. S., Forsling M., Bannister R. Blood pressure and vasopressin in progressive autonomic failure. Response to postural stimulation, L-dopa and naloxone. Brain. 1983 Jun;106(Pt 2):503–511. doi: 10.1093/brain/106.2.503. [DOI] [PubMed] [Google Scholar]
  29. Raskind M. A., Peskind E. R., Veith R. C., Wilkinson C. W., Federighi D., Dorsa D. M. Differential effects of aging on neuroendocrine responses to physostigmine in normal men. J Clin Endocrinol Metab. 1990 May;70(5):1420–1425. doi: 10.1210/jcem-70-5-1420. [DOI] [PubMed] [Google Scholar]
  30. Robertson G. L. The regulation of vasopressin function in health and disease. Recent Prog Horm Res. 1976;33:333–385. doi: 10.1016/b978-0-12-571133-3.50015-5. [DOI] [PubMed] [Google Scholar]
  31. Ruggiero D. A., Cravo S. L., Arango V., Reis D. J. Central control of the circulation by the rostral ventrolateral reticular nucleus: anatomical substrates. Prog Brain Res. 1989;81:49–79. doi: 10.1016/s0079-6123(08)61999-8. [DOI] [PubMed] [Google Scholar]
  32. Schrag A., Good C. D., Miszkiel K., Morris H. R., Mathias C. J., Lees A. J., Quinn N. P. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology. 2000 Feb 8;54(3):697–702. doi: 10.1212/wnl.54.3.697. [DOI] [PubMed] [Google Scholar]
  33. Schrag A., Kingsley D., Phatouros C., Mathias C. J., Lees A. J., Daniel S. E., Quinn N. P. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):65–71. doi: 10.1136/jnnp.65.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Senda Y., Koike Y., Oiso Y., Matsuoka Y., Takahashi A. [Plasma vasopressin responses to orthostasis and hypertonic saline infusion in progressive autonomic failure]. Rinsho Shinkeigaku. 1988 Nov;28(11):1282–1289. [PubMed] [Google Scholar]
  35. Spyer K. M. Annual review prize lecture. Central nervous mechanisms contributing to cardiovascular control. J Physiol. 1994 Jan 1;474(1):1–19. doi: 10.1113/jphysiol.1994.sp019997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Thomaides T. N., Chaudhuri K. R., Maule S., Watson L., Marsden C. D., Mathias C. J. Growth hormone response to clonidine in central and peripheral primary autonomic failure. Lancet. 1992 Aug 1;340(8814):263–266. doi: 10.1016/0140-6736(92)92355-j. [DOI] [PubMed] [Google Scholar]
  37. Wenning G. K., Ben Shlomo Y., Magalhães M., Daniel S. E., Quinn N. P. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain. 1994 Aug;117(Pt 4):835–845. doi: 10.1093/brain/117.4.835. [DOI] [PubMed] [Google Scholar]
  38. Williams T. D., Lightman S. L., Bannister R. Vasopressin secretion in progressive autonomic failure: evidence for defective afferent cardiovascular pathways. J Neurol Neurosurg Psychiatry. 1985 Mar;48(3):225–228. doi: 10.1136/jnnp.48.3.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Winkler A. S., Marsden J., Parton M., Watkins P. J., Chaudhuri K. R. Erythropoietin deficiency and anaemia in multiple system atrophy. Mov Disord. 2001 Mar;16(2):233–239. doi: 10.1002/mds.1063. [DOI] [PubMed] [Google Scholar]
  40. Winkler Andrea Sylvia, Landau Sabine, Chaudhuri K. Ray. Serum prolactin levels in Parkinson's disease and multiple system atrophy. Clin Auton Res. 2002 Oct;12(5):393–398. doi: 10.1007/s10286-002-0025-y. [DOI] [PubMed] [Google Scholar]
  41. Zerbe R. L., Henry D. P., Robertson G. L. Vasopressin response to orthostatic hypotension. Etiologic and clinical implications. Am J Med. 1983 Feb;74(2):265–271. doi: 10.1016/0002-9343(83)90625-3. [DOI] [PubMed] [Google Scholar]
  42. Ziegler M. G., Lake C. R., Kopin I. J. The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med. 1977 Feb 10;296(6):293–297. doi: 10.1056/NEJM197702102960601. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES